IL-6 may also show potential in the diagnosis of non-alcoholic fatty liver disease with metabolic dysfunction, as well as in complications related to the urinary system, regardless of sex. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.